Myomo names Mary-Katherine McClure chief commercial officer as Micah Mitchell exits

By Public Technologies
  • Myomo named Mary-Katherine “Katie” McClure chief commercial officer, effective Oct. 12, 2026.
  • McClure joins from Inspire Medical Systems, where she worked since 2018 amid revenue growth from about $50 million to nearly $1 billion.
  • Earlier roles included senior medical device sales posts at Medtronic, Tobii Dynavox, Johnson & Johnson.
  • Outgoing chief commercial officer Micah Mitchell will depart following a transition period ending Dec. 23, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myomo Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610121605BIZWIRE_USPR_____20261012_BW506126) on October 12, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk